Loxapine Tablets Suppliers & Bulk Manufacturers
Available Forms: Oral Capsules
Available Strengths: 5 mg, 10 mg, 25 mg, 50 mg
Reference Brands: Loxitane®(US)
Category:
Antipsychotropic Drugs
Loxapine is a typical antipsychotic that primarily works by blocking dopamine D2 and serotonin 5-HT2 receptors in the brain, helping to reduce symptoms of psychosis such as hallucinations, delusions, and agitation. Loxapine tablets are used in the treatment of schizophrenia and other chronic psychotic disorders, providing effective oral symptom control in long-term psychiatric care.
Loxapine Tablets is available in Oral Capsules
and strengths such as 5 mg, 10 mg, 25 mg, 50 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Loxapine Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Loxapine Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Loxapine tablets are FDA-approved in the United States for the treatment of schizophrenia and are used off-label for other psychotic disorders. In the EU, Loxapine is approved in select countries under national procedures, primarily for managing chronic schizophrenia. Regulatory requirements include compliance with GMP standards, bioequivalence studies, psychiatric safety data, and labeling that highlights sedation and extrapyramidal risk. EU registration may require bridging data if centrally approved alternatives exist. For global buyers seeking dossier-ready Loxapine tablets and other forms such as inhalation powder, visit Pharmatradz.com — your trusted B2B platform for pharmaceutical sourcing.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing